@sash1e's testosterone therapy story needs context
Quick answer
Testosterone therapy in transgender men produces well-documented physical changes including vocal pitch lowering, clitoral hypertrophy, and androgenic alopecia, but the magnitude and psychological impact of these changes varies significantly between individuals. The creator's claim that bottom growth alleviates "all" dysphoria overstates what hormone therapy alone can achieve, as clinical guidelines from WPATH and the Endocrine Society recommend individualized care that often includes psychological support alongside hormonal treatment. Hair loss from testosterone is a real, genetically influenced risk that the creator acknowledged honestly, and this kind of informed expectation-setting is more useful to viewers than blanket reassurance.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @sash1e actually say?
In a comedic storytime format, @sash1e walked through their pre-testosterone fears and told their past self, essentially, to relax. The claims were specific: testosterone made their singing voice "so much better" that they became a semi-finalist on The Voice, "bottom growth" became their "favorite side effect" and "alleviates all of your dysphoria," and hair loss happened but was something they "learned to live with." They also pushed back on fears about regretting transition, framing long-held gender identity as strong evidence of being trans. The video is comedy, not a medical tutorial, but with 566K views, the health claims land whether or not the creator intended them to.
Does the science back this up?
Partially, yes, and the parts that are wrong are more nuanced than dangerous. Testosterone does cause vocal changes in transgender men, clitoral growth (bottom growth), and androgenic hair loss in those genetically predisposed. What the science does not support is the idea that these effects are universally positive or predictable, and "alleviates all dysphoria" is a significant overstatement.
On voice: testosterone causes laryngeal growth and vocal fold thickening, which lowers pitch. A 2017 study by Azul et al. in the International Journal of Language and Communication Disorders found that vocal outcomes varied considerably among trans masculine people, with some reporting satisfaction and others reporting ongoing dissatisfaction or instability. Becoming a competitive singer is a real possibility, but it is not a guaranteed upgrade.
On bottom growth (clitoral hypertrophy): this is a well-documented effect of testosterone. It typically begins within the first few months. Research by Tamar-Mattis et al. and clinical data from UCSF's Transgender Care program confirm it is among the earliest and most consistent physical changes. Whether it alleviates dysphoria is individual.
On hair loss: @sash1e's candid admission that "we learned to live with it" is actually the most scientifically honest thing in the video. Androgenic alopecia in trans masculine people on testosterone is real, common, and not reversible upon stopping testosterone for most people.
What did they get wrong (or right)?
The biggest overclaim is that bottom growth "alleviates all of your dysphoria." That phrasing sets an expectation no body part can meet for everyone. Gender dysphoria is not a single-symptom condition. A 2021 systematic review by Aldridge et al. in Psychological Medicine found that hormone therapy significantly reduced psychological distress in many trans people, but individual variation was wide and some people required additional support including therapy and surgical options. "All" dysphoria going away from one physical change is not what the literature shows.
What they got right: the general direction of the effects they described is accurate. Voice changes, bottom growth, and hair thinning are all real, documented effects of testosterone in trans masculine people. Their framing of long-held gender identity as evidence of being trans aligns with clinical guidelines from WPATH and the Endocrine Society, which treat persistent, well-established gender incongruence as sufficient basis for care. The fear of "not really being trans" is common and clinically recognized. @sash1e's response to it, while profane, is not medically wrong.
What should you actually know?
Testosterone masculinization is well-studied, but individual outcomes differ. Here is what the evidence actually supports:
- Vocal changes from testosterone are permanent but not always linear or predictable. Some trans masculine singers report needing significant retraining. Working with a voice coach experienced in trans voice is advisable, not optional.
- Clitoral hypertrophy is nearly universal on testosterone and begins early, but its psychological effect ranges from profoundly relieving to neutral to distressing depending on the individual.
- Hair loss risk depends heavily on genetics. If you have family history of androgenic alopecia, testosterone increases your odds significantly. This is worth discussing with a provider before starting.
- Regret rates for gender-affirming hormone therapy are low in the literature. A 2021 study by Bustos et al. in Plastic and Reconstructive Surgery Global Open found regret rates of around 1% for hormonal interventions, though the authors noted study limitations including follow-up length.
- Dysphoria reduction from hormones is real and statistically significant across multiple studies, but it is not complete or guaranteed for every person. Mental health support alongside hormone therapy produces better outcomes than hormones alone.
This video is not medical advice and was not presented as such. But people watching it at scale will form expectations. Those expectations should be calibrated, not just excited.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @sash1e's testosterone therapy story needs context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@sash1e's testosterone therapy story needs context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Testosterone therapy in transgender men produces well-documented physical changes including vocal pitch lowering, clitoral hypertrophy, and androgenic alopecia, but the magnitude and psychological impact of these changes varies significantly between individuals.
FormBlends verdict
Testosterone therapy in transgender men produces well-documented physical changes including vocal pitch lowering, clitoral hypertrophy, and androgenic alopecia, but the magnitude and psychological impact of these changes varies significantly between individuals. The creator's claim that bottom growth alleviates "all" dysphoria overstates what hormone therapy alone can achieve, as clinical guidelines from WPATH and the Endocrine Society recommend individualized care that often includes psychological support alongside hormonal treatment. Hair loss from testosterone is a real, genetically influenced risk that the creator acknowledged honestly, and this kind of informed expectation-setting is more useful to viewers than blanket reassurance.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone therapy in transgender men produces well-documented physical changes including vocal pitch lowering, clitoral hypertrophy, and androgenic alopecia, but the magnitude and psychological impact of these changes varies significantly between individuals. The creator's claim that bottom growth alleviates "all" dysphoria overstates what hormone therapy alone can achieve, as clinical guidelines from WPATH and the Endocrine Society recommend individualized care that often includes psychological support alongside hormonal treatment. Hair loss from testosterone is a real, genetically influenced risk that the creator acknowledged honestly, and this kind of informed expectation-setting is more useful to viewers than blanket reassurance.
- Testosterone does lower vocal pitch, but a 2017 study by Azul et al. found outcomes varied widely and some trans masculine singers required significant retraining to adapt.
- Clitoral hypertrophy (bottom growth) is one of the earliest and most consistent effects of testosterone, typically beginning within the first 1 to 3 months of treatment.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Testosterone does lower vocal pitch, but a 2017 study by Azul et al. found outcomes varied widely and some trans masculine singers required significant retraining to adapt.
- Clitoral hypertrophy (bottom growth) is one of the earliest and most consistent effects of testosterone, typically beginning within the first 1 to 3 months of treatment.
- Dysphoria reduction from hormone therapy is statistically significant across multiple studies, but Aldridge et al. (2021) found it is rarely complete, and mental health support alongside hormones produces better outcomes.
- Regret rates for hormonal gender-affirming care are approximately 1% according to Bustos et al. (2021), though study follow-up limitations mean that number should be understood as a lower bound, not a guarantee.
- Androgenic alopecia risk from testosterone is real and tied to genetics. People with family history of hair loss should discuss this with a provider before starting therapy, as it is largely irreversible.
- This video is comedy, but health claims made to 566K viewers carry weight regardless of intent. The directional accuracy is generally okay; the absolute language ("all dysphoria," "so much better") is where it overshoots the evidence.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
sasha allen · TikTok creator
566.3K views on this video
i was SO UGLY. so ugly nd so dumb - #fyp #lgbt #trans #gay #storytime #comedy #trending
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by sasha allen, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.